Ribomic Inc. is a clinical stage pharmaceutical company dedicated to advancing aptamer therapeutics, with a particular focus on rare diseases and ophthalmology. Its lead candidate, RBM-007, is in Phas
e 2a for achondroplasia, and has also completed Phase 1/2a for wet AMD.
LikeShareFollow
| RibomicInc |
| Ribomic Inc. is a clinical stage pharmaceutical company dedicated to advancing aptamer therapeutics, with a particular focus on rare diseases and ophthalmology. Its lead candidate, RBM-007, is in Phase 2a for achondroplasia, and has also completed Phase 1/2a for wet AMD. |
| Ribomic Inc. is a clinical stage pharmaceutical company dedicated to advancing aptamer therapeutics, with a particular focus on rare diseases and ophthalmology. Its lead candidate, RBM-007, is in Phase 2a for achondroplasia, and has also completed Phase 1/2a for wet AMD. |
Trusted Seller
| ||||||||||
